Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$2.35 - $3.47 $981,519 - $1.45 Million
-417,668 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$2.92 - $5.74 $2.01 Million - $3.95 Million
-687,504 Reduced 62.21%
417,668 $1.35 Million
Q3 2021

Nov 15, 2021

BUY
$4.98 - $6.63 $5.24 Million - $6.97 Million
1,051,990 Added 1978.09%
1,105,172 $5.8 Million
Q2 2021

Aug 16, 2021

BUY
$2.56 - $5.49 $136,145 - $291,969
53,182 New
53,182 $292,000

Others Institutions Holding AGEN

About AGENUS INC


  • Ticker AGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 283,163,008
  • Market Cap $4.73B
  • Description
  • Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...
More about AGEN
Track This Portfolio

Track Voloridge Investment Management, LLC Portfolio

Follow Voloridge Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voloridge Investment Management, LLC with notifications on news.